Tacrolimus ointment: Utilization patterns in children under age 2 years

Dermatology Online Journal

Volumn 10, Issue 1, 2004, Pages

  Housman, Tamara Salam ^a   Norton, Amy B ^a   Feldman, Steven R ^a   Fleischer Jr , Alan B ^a   Simpson, Eric L ^b   Hanifin, Jon M ^b   Antaya, Richard J ^c  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^c YALE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTIHISTAMINIC AGENT; CORTICOSTEROID; TACROLIMUS;

ATOPIC DERMATITIS; BURNING SENSATION; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; DRUG UTILIZATION; FEMALE; FOLLOW UP; HUMAN; INFANT; MALE; MEDICAL PRACTICE; PAIN; PRESCHOOL CHILD; PRURITUS; RACE DIFFERENCE; REVIEW; SIDE EFFECT;

EID: 6044233377     PISSN: 10872108     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (10)

1. Kristal L, Klein PA. Atopic dermatitis in infants and children. An update. Pediatr Clin North Am 2000;47:877-95.
2. Laughter D, Istvan JA, Tofte SJ, Hanifin JM. The prevalence of atopic dermatitis in Oregon schoolchildren. J Am Acad Dermatol 2000;43:649-55.
3. Diepgen TL, Fartasch M. Recent epidemiological and genetic studies in atopic dermatitis. Acta Derm Venereol Suppl (Stockh) 1992;176:13-8.
4. Kang S, Lucky AW, Pariser D, Lawrence I, Hanifin JM. Long-term safety and efficacy of tacrolimus ointment for the treatment of atopic dermatitis in children. J Am Acad Dermatol 2001;44:S58-S64.
5. Paller A, Eichenfield LF, Leung DY, Stewart D, Appell M. A 12-week study of tacrolimus ointment for the treatment of atopic dermatitis in pediatric patients. J Am Acad Dermatol 2001;44:S47-S57.
6. Liu J, Farmer JD, Jr., Lane WS, Friedman J, Weissman I, Schreiber SL. Calcineurin is a common 66:807target of cyclophilin-cyclosporin A and FKBP-FK506 complexes. Cell. 1991 Aug 23;66(4):807-15.
7. Hanifin JM, Chan S. Biochemical and immunologic mechanisms in atopic dermatitis: new targets for emerging therapies. J Am Acad Dermatol 1999;41:72-7.
8. Metry DW, Hebert AA. Topical therapies and medications in the pediatric patient. Pediatr Clin North Am 2000;47:867-76.
9. Alaiti S, Kang S, Fiedler VC, Ellis CN, Spurlin DV, Fader D et al. Tacrolimus (FK506) ointment for atopic dermatitis: a phase I study in adults and children. J Am Acad Dermatol 1998;38:69-76.
10. Bieber T. Topical tacrolimus (FK 506): a new milestone in the management of atopic dermatitis. J Allergy Clin Immunol 1998;102:555-7.